Genetic screening identifies glial adenosine as a therapeutic target in alpha-synucleinopathy
Maggie Sodders, E Okorie, H Tahmasebidehkordi, Archana Marathi, N Kumari, M Lakhani, A Schiro, M Shen, N Sriram, Souvarish Sarkar, Abby L. Olsen
A Drosophila genetic screen identifies glial adenosine metabolism genes as therapeutic targets for alpha-synucleinopathies by improving locomotion and reducing neurodegeneration.
bioRxiv · May 15, 2024 · PreprintNeuroscience